Paper7309718
Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
Tsuji S and 3 others. J Biochem, 1981. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). Papers, record 7309718. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7309718
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Gland Diseases | Major topic |
| Fatty Acids | Major topic |
| Lipid Metabolism, Inborn Errors | Major topic |
| Cells, Cultured | |
| Chromatography, Gas | |
| Fibroblasts | |
| Humans | |
| Stearic Acids |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42469918 | The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42469918 | PubMed |
| 40428412 | Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40428412 | PubMed |
| 38795862 | Four-dimensional lipidomics profiling in X-linked adrenoleukodystrophy using trapped ion mobility mass spectrometry. | J Lipid Res | 2024 | https://conductscience.org/library/papers/38795862 | PubMed |
| 37656183 | System-based integrated metabolomics and microRNA analysis identifies potential molecular alterations in human X-linked cerebral adrenoleukodystrophy brain. | Hum Mol Genet | 2023 | https://conductscience.org/library/papers/37656183 | PubMed |
| 32075856 | Hexacosenoyl-CoA is the most abundant very long-chain acyl-CoA in ATP binding cassette transporter D1-deficient cells. | J Lipid Res | 2020 | https://conductscience.org/library/papers/32075856 | PubMed |
| 31909500 | X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. | Int J Dev Neurosci | 2020 | https://conductscience.org/library/papers/31909500 | PubMed |
| 26843114 | MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy. | Mol Neurobiol | 2017 | https://conductscience.org/library/papers/26843114 | PubMed |
| 25393703 | ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. | J Neurochem | 2015 | https://conductscience.org/library/papers/25393703 | PubMed |
| 25255441 | Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice. | PLoS One | 2014 | https://conductscience.org/library/papers/25255441 | PubMed |
| 25115486 | X-linked adrenoleukodystrophy: pathogenesis and treatment. | Curr Neurol Neurosci Rep | 2014 | https://conductscience.org/library/papers/25115486 | PubMed |
| 22447153 | Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation. | J Inherit Metab Dis | 2012 | https://conductscience.org/library/papers/22447153 | PubMed |
| 21399389 | Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible? | J Endocrinol Invest | 2011 | https://conductscience.org/library/papers/21399389 | PubMed |
| 20626744 | Biochemical aspects of X-linked adrenoleukodystrophy. | Brain Pathol | 2010 | https://conductscience.org/library/papers/20626744 | PubMed |
| 20626742 | Schilder's disease a heterogenous group of disorders known as X-linked adrenoleukodystrophy. Foreword. | Brain Pathol | 2010 | https://conductscience.org/library/papers/20626742 | PubMed |
| 20166112 | The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. | EMBO Mol Med | 2010 | https://conductscience.org/library/papers/20166112 | PubMed |
| 19605772 | Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology. | J Child Neurol | 2009 | https://conductscience.org/library/papers/19605772 | PubMed |
| 15139299 | Evaluation of therapy of X-linked adrenoleukodystrophy. | Neurochem Res | 2004 | https://conductscience.org/library/papers/15139299 | PubMed |
| 11916318 | Decreasing serum VLCFA levels in ageing X-ALD female carriers. | J Inherit Metab Dis | 2001 | https://conductscience.org/library/papers/11916318 | PubMed |
| 10449548 | Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil". | J Neurol Neurosurg Psychiatry | 1999 | https://conductscience.org/library/papers/10449548 | PubMed |
| 9221959 | X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. | J Neurol Neurosurg Psychiatry | 1997 | https://conductscience.org/library/papers/9221959 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7309718
GET https://conductscience.org/api/papers/v1/7309718/cited_by?page=2